ArticleFrontiers in immunology2025

Combined treatment with anti-PSMA antibody and human peripheral blood-derived NK cells for castration-resistant prostate cancer.

Fangming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.